Climb Bio Statistics Share Statistics Climb Bio has 67.76M
shares outstanding. The number of shares has increased by 0.77%
in one year.
Shares Outstanding 67.76M Shares Change (YoY) 0.77% Shares Change (QoQ) 0.15% Owned by Institutions (%) n/a Shares Floating 58.65M Failed to Deliver (FTD) Shares 865 FTD / Avg. Volume 0.16%
Short Selling Information The latest short interest is 878.95K, so 1.3% of the outstanding
shares have been sold short.
Short Interest 878.95K Short % of Shares Out 1.3% Short % of Float 2.42% Short Ratio (days to cover) 1.98
Valuation Ratios The PE ratio is -1.17 and the forward
PE ratio is -2.84.
Climb Bio's PEG ratio is
-0.07.
PE Ratio -1.17 Forward PE -2.84 PS Ratio 0 Forward PS n/a PB Ratio 0.41 P/FCF Ratio -5.57 PEG Ratio -0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Climb Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 31.41,
with a Debt / Equity ratio of 0.
Current Ratio 31.41 Quick Ratio 31.41 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.35M Employee Count 17 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -57.23% in the
last 52 weeks. The beta is -0.04, so Climb Bio's
price volatility has been lower than the market average.
Beta -0.04 52-Week Price Change -57.23% 50-Day Moving Average 1.98 200-Day Moving Average 1.63 Relative Strength Index (RSI) 48.52 Average Volume (20 Days) 544,888
Income Statement
Revenue n/a Gross Profit n/a Operating Income -82.02M Net Income -73.9M EBITDA -30.36M EBIT -30.36M Earnings Per Share (EPS) -1.53
Full Income Statement Balance Sheet The company has 87.23M in cash and 532K in
debt, giving a net cash position of 86.7M.
Cash & Cash Equivalents 87.23M Total Debt 532K Net Cash 86.7M Retained Earnings -229.88M Total Assets 192.39M Working Capital 81.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -15.56M
and capital expenditures 0, giving a free cash flow of -15.56M.
Operating Cash Flow -15.56M Capital Expenditures n/a Free Cash Flow -15.56M FCF Per Share -0.32
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
